About Natera
Natera is a company based in Redwood City (United States) founded in 2004.. Natera has raised $152.1 million across 13 funding rounds from investors including Lightspeed Venture Partners, Franklin Templeton and HHS. The company has 4,430 employees as of December 31, 2024. Natera has completed 1 acquisition, including Foresight Diagnostics. Natera offers products and services including Signatera, Panorama, Prospera, Horizon, and Renasight. Natera operates in a competitive market with competitors including Guardant Health, Foundation Medicine, ArcherDX, Prenetics and Veracyte, among others.
- Headquarter Redwood City, United States
- Employees 4430 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Natera, Inc.
-
Annual Revenue
$1.7 B56.75as on Dec 31, 2024
-
Net Profit
$-190.43 M56.2as on Dec 31, 2024
-
EBITDA
$-191.33 M52.75as on Dec 31, 2024
-
Total Equity Funding
$152.1 M (USD)
in 13 rounds
-
Latest Funding Round
$287.5 M (USD), Post-IPO
Apr 13, 2020
-
Investors
Lightspeed Venture Partners
& 14 more
-
Employee Count
4430
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Natera
Natera is a publicly listed company on the NASDAQ with ticker symbol NTRA in USA, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Natera
Natera offers a comprehensive portfolio of products and services, including Signatera, Panorama, Prospera, Horizon, and Renasight. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Detects residual disease in cancer patients through DNA analysis
Screens for genetic conditions in prenatal testing
Assesses transplant organ health via DNA monitoring
Provides carrier screening for genetic disorders
Evaluates kidney gene panels for health risks
Unlock access to complete
Unlock access to complete
Leadership Team
124 people
Software Development Team
90 people
Product Management Team
75 people
Senior Team
70 people
Sales and Marketing
66 people
Data Analysis and Operations Team
35 people
Clinical Team
33 people
Operations Team
22 people
Unlock access to complete
Funding Insights of Natera
Natera has successfully raised a total of $152.1M across 13 strategic funding rounds. The most recent funding activity was a Post-IPO round of $287.5 million completed in April 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 13
- Last Round Post-IPO — $287.5M
-
First Round
First Round
(01 Aug 2006)
- Investors Count 15
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2020 | Amount | Post-IPO - Natera | Valuation |
investors |
|
| Apr, 2015 | Amount | Series F - Natera | Valuation |
investors |
|
| May, 2013 | Amount | Series E - Natera | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Natera
Natera has secured backing from 15 investors, including venture fund and institutional investors. Prominent investors backing the company include Lightspeed Venture Partners, Franklin Templeton and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biotech funding, drug development support, and investment in life sciences.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Natera
Natera has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Foresight Diagnostics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Minimally invasive liquid biopsy tests for cancer detection are developed.
|
2020 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Natera
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Natera Comparisons
Competitors of Natera
Natera operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Foundation Medicine, ArcherDX, Prenetics and Veracyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Health risks are identified through online genetic and diagnostic testing.
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Natera
Frequently Asked Questions about Natera
When was Natera founded?
Natera was founded in 2004 and raised its 1st funding round 2 years after it was founded.
Where is Natera located?
Natera is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Is Natera a funded company?
Natera is a funded company, having raised a total of $152.1M across 13 funding rounds to date. The company's 1st funding round was a Series E of $54.6M, raised on Aug 01, 2006.
How many employees does Natera have?
As of Dec 31, 2024, the latest employee count at Natera is 4,430.
What is the annual revenue of Natera?
Annual revenue of Natera is $1.7B as on Dec 31, 2024.
What does Natera do?
Developer of cell-free DNA testing for oncology, womens health, and organ health. The test provided by the company inlcude Signatera a residual disease test (MRD), Altera tumor genomic profile, Empower Hereditary cancer test, Prospera Kidney transplant assessment, Panorama Noninvasive prenatal testing (NIPT), Anora Miscarriage Test, and more.
Who are the top competitors of Natera?
Natera's top competitors include Guardant Health, Exact Sciences and Foundation Medicine.
What products or services does Natera offer?
Natera offers Signatera, Panorama, Prospera, Horizon, and Renasight.
Is Natera publicly traded?
Yes, Natera is publicly traded on NASDAQ under the ticker symbol NTRA.
How many acquisitions has Natera made?
Natera has made 1 acquisition, including Foresight Diagnostics.
Who are Natera's investors?
Natera has 15 investors. Key investors include Lightspeed Venture Partners, Franklin Templeton, HHS, Orbimed, and RA Capital.
What is Natera's ticker symbol?
The ticker symbol of Natera is NTRA on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.